JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M401800200 on April 19, 2004

J. Biol. Chem., Vol. 279, Issue 25, 26314-26322, June 18, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/25/26314    most recent
M401800200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mao, H.
Right arrow Articles by Albert, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mao, H.
Right arrow Articles by Albert, P. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

RGS17/RGSZ2, a Novel Regulator of Gi/o, Gz, and Gq Signaling*

Helen Mao{ddagger}§, Qingshi Zhao§, Mireille Daigle{ddagger}, Mohammad H. Ghahremani{ddagger}, Peter Chidiac¶||, and Paul R. Albert{ddagger}**

From the {ddagger}Department of Neuroscience, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada and Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario N6A 5C1, Canada

To identify novel regulators of G{alpha}o, the most abundant G-protein in brain, we used yeast two-hybrid screening with constitutively active G{alpha}o as bait and identified a new regulator of G-protein signaling (RGS) protein, RGS17 (RGSZ2), as a novel human member of the RZ (or A) subfamily of RGS proteins. RGS17 contains an amino-terminal cysteine-rich motif and a carboxyl-terminal RGS domain with highest homology to hRGSZ1- and hRGS-G{alpha}-interacting protein. RGS17 RNA was strongly expressed as multiple species in cerebellum and other brain regions. The interactions between hRGS17 and active forms of G{alpha}i1–3, G{alpha}o, G{alpha}z, or G{alpha}q but not G{alpha}s were detected by yeast two-hybrid assay, in vitro pull-down assay, and co-immunoprecipitation studies. Recombinant RGS17 acted as a GTPase-activating protein (GAP) on free G{alpha}i2 and G{alpha}o under pre-steady-state conditions, and on M2-muscarinic receptor-activated G{alpha}i1, G{alpha}i2, G{alpha}i3, G{alpha}z, and G{alpha}o in steady-state GTPase assays in vitro. Unlike RGSZ1, which is highly selective for Gz, RGS17 exhibited limited selectivity for Go among Gi/Go proteins. All RZ family members reduced dopamine-D2/G{alpha}i-mediated inhibition of cAMP formation and abolished thyrotropin-releasing hormone receptor/G{alpha}q-mediated calcium mobilization. RGS17 is a new RZ member that preferentially inhibits receptor signaling via Gi/o, Gz, and Gq over Gs to enhance cAMP-dependent signaling and inhibit calcium signaling. Differences observed between in vitro GAP assays and whole-cell signaling suggest additional determinants of the G-protein specificity of RGS GAP effects that could include receptors and effectors.


Received for publication, February 18, 2004 , and in revised form, April 9, 2004.

* This research was supported by grants from the Ontario Mental Health Foundation (to P. R. A.) and the Canadian Institutes of Health Research (to P. R. A. and P. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

|| To whom correspondence should be addressed. Tel.: 519-661-3318; Fax: 519-661-3827; E-mail: peter.chidiac{at}fmd.uwo.ca. ** To whom correspondence should be addressed. Tel.: 613-562-5800, ext. 8307; Fax: 613-562-5403; E-mail: palbert{at}uottawa.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. E. Feigin and C. C. Malbon
RGS19 regulates Wnt beta-catenin signaling through inactivation of G{alpha}o
J. Cell Sci., October 1, 2007; 120(19): 3404 - 3414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Garzon, M. Rodriguez-Munoz, A. Lopez-Fando, and P. Sanchez-Blazquez
Activation of {micro}-Opioid Receptors Transfers Control of G{alpha} Subunits to the Regulator of G-protein Signaling RGS9-2: ROLE IN RECEPTOR DESENSITIZATION
J. Biol. Chem., March 11, 2005; 280(10): 8951 - 8960.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Hahn, T. K. Bera, K. Gehlhaus, I. R. Kirsch, I. H. Pastan, and B. Lee
Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases
PNAS, September 7, 2004; 101(36): 13257 - 13261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.